Treatment dilemmas in patients with gastrointestinal stromal tumors (GIST) who experienced imatinib-induced pneumonitis: A case series

Treatment dilemmas in patients with gastrointestinal stromal tumors (GIST) who experienced imatinib-induced pneumonitis: A case series

Introduction: Imatinib has led to a phenomenal progress in the treatment of GIST. A rare and lesser-known side effect of imatinib is pneumonitis, an uncommon multicausal interstitial lung disease. Methods: Patients registered within the Dutch GIST Registry (DGR) were reviewed. For the patients ident...

Full description

Bibliographic Details
Main Authors: Deborah van de Wal, Evelyne Roets, Roos F. Bleckman, Jorn Nützinger, Birthe C. Heeres, J. Martijn Kerst, Mahmoud Mohammadi, Anna K.L. Reyners, Ingrid M.E. Desar, Astrid W. Oosten, Neeltje Steeghs, Winette T.A. van der Graaf
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Current Problems in Cancer: Case Reports
Subjects:
Imatinib
Adverse event
GIST
Pneumonitis
Interstitial lung disease
Case series
Online Access:http://www.sciencedirect.com/science/article/pii/S2666621924000036

Internet

http://www.sciencedirect.com/science/article/pii/S2666621924000036

Similar Items